# Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss

> **NCT02345031** · PHASE2 · COMPLETED · sponsor: **Autifony Therapeutics Limited** · enrollment: 78 (actual)

## Conditions studied

- Age-Related Hearing Loss

## Interventions

- **DRUG:** AUT00063
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02345031
- **Lead sponsor:** Autifony Therapeutics Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2016-05
- **Final completion:** 2016-06
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2018-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02345031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02345031, "Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02345031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*